One of the charges leveled against silicone breast implants that led to their temporary ban by the FDA from sale for breast augmentation in the United States was a suspected tie to breast cancer. A recently published study, which has the longest follow-up of any study to date, shows that this charge was unjustified as there seems to be no increased breast cancer risk for women with breast implants.
The study, published in the January 2009 issue of the International Journal of Cancer, followed 3486 Swedish and 2736 Danish women who had cosmetic breast augmentation between 1965 and 1993. Cancer incidence through 2002 was ascertained for the women and compared to nationwide cancer registries. On average, women were followed for 16.6 years, and some women were tracked over the entire length of the study, from 1965-2002, 37 years.
The women in the study actually had reduced rates of breast cancer, with an incidence only 73 % of that in the general population. Among the women, the only cancer that occurred with frequency above that of the general population was lung cancer, which was attributed to the prevalence of smokers among the study population.
This study shows again that most of the so-called risks that led to the temporary ban of silicone breast implants were the product of hysteria rather than good science. If safety concerns have kept you from getting breast augmentation, schedule a breast implant safety consultation with Dr. George Lefkovits today to learn the truth.